ARTICLE | Distillery Therapeutics
Therapeutics: Tetratricopeptide repeat domain 39B (TTC39B)
July 21, 2016 7:00 AM UTC
Mouse studies suggest inhibiting TTC39B could help treat atherosclerosis and NASH. In mice fed a high-fat, high-cholesterol and bile salt diet, systemic or liver-specific TTC39B knockout increased ser...